Evidence map›Paper›PMID 38592543›Full record

ArticleBreast cancer research and treatment2024

Correction: Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium.

Mariana Brandão, Diogo Martins-Branco, Claudia De Angelis, Peter Vuylsteke, Richard D Gelber, Nancy Van Damme, Lien van Walle, Arlindo R Ferreira, Matteo Lambertini, Francesca Poggio and 9 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Breast cancer research and treatment, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Mariana Brandão *Academic Trials Promoting Team (ATPT), Institut Jules Bordet, Hôpital Universitaire de Bruxelles (HUB), Université Libre de Bruxelles (ULB), Brussels, Belgium.ORCID https://orcid.org/0000-0002-1653-3544
Diogo Martins-Branco *Academic Trials Promoting Team (ATPT), Institut Jules Bordet, Hôpital Universitaire de Bruxelles (HUB), Université Libre de Bruxelles (ULB), Brussels, Belgium.ORCID https://orcid.org/0000-0002-7214-4818
Claudia De AngelisAcademic Trials Promoting Team (ATPT), Institut Jules Bordet, Hôpital Universitaire de Bruxelles (HUB), Université Libre de Bruxelles (ULB), Brussels, Belgium.ORCID https://orcid.org/0000-0003-0398-5610
Peter VuylstekeCHU UCL Namur, Site Ste Elisabeth, UC Louvain, Namur, Belgium.ORCID https://orcid.org/0000-0001-6401-3722
Richard D GelberDepartment of Data Science, Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health, Frontier Science Foundation, Boston, USA.ORCID https://orcid.org/0000-0001-8270-8712
Nancy Van DammeDepartment of Data Science, Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health, Frontier Science Foundation, Boston, USA.ORCID https://orcid.org/0000-0003-4636-7636
Lien van WalleBelgian Cancer Registry, Brussels, Belgium.ORCID https://orcid.org/0000-0001-7356-8877
Arlindo R FerreiraBreast Unit, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal.ORCID https://orcid.org/0000-0002-1567-9322
Matteo LambertiniDepartment of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa, Italy.ORCID https://orcid.org/0000-0003-1797-5296
Francesca PoggioDepartment of Medical Oncology, U.O. Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.ORCID https://orcid.org/0000-0002-4518-2827
Didier VerhoevenMedical Oncology, AZ Klina, University of Antwerp, Antwerp, Belgium.ORCID https://orcid.org/0000-0002-7748-0837
Annelore BarbeauxMedical Oncology, CHR Verviers East Belgium, Verviers, Belgium.ORCID https://orcid.org/0000-0003-4003-0864
Francois P DuhouxDepartment of Medical Oncology, Institut Roi Albert II, Cliniques Universitaires Saint-Luc, Brussels, Belgium.ORCID https://orcid.org/0000-0002-5429-7888
Hans WildiersDepartment of General Medical Oncology and Multidisciplinary Breast Centre, Leuven Cancer Institute and University Hospitals Leuven, Louvain, Belgium.ORCID https://orcid.org/0000-0001-8990-7837
Carmela CaballeroBreast International Group, Brussels, Belgium.ORCID https://orcid.org/0000-0002-3586-6598
Ahmad AwadaMedical Oncology Department, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (HUB), Université Libre de Bruxelles (ULB), Brussels, Belgium.ORCID https://orcid.org/0000-0001-7412-9163
Martine Piccart-GebhartMedical Oncology Department, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (HUB), Université Libre de Bruxelles (ULB), Brussels, Belgium.ORCID https://orcid.org/0000-0001-9068-8504
Kevin PunieDepartment of General Medical Oncology and Multidisciplinary Breast Centre, Leuven Cancer Institute and University Hospitals Leuven, Louvain, Belgium.ORCID https://orcid.org/0000-0002-1162-7963
Evandro de AzambujaAcademic Trials Promoting Team (ATPT), Institut Jules Bordet, Hôpital Universitaire de Bruxelles (HUB), Université Libre de Bruxelles (ULB), Brussels, Belgium. evandro.deazambuja@hubruxelles.be.ORCID https://orcid.org/0000-0001-9501-4509

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38592543

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.